Topic Highlight
Copyright ©The Author(s) 2015.
World J Hepatol. Jan 27, 2015; 7(1): 1-6
Published online Jan 27, 2015. doi: 10.4254/wjh.v7.i1.1
Table 2 Representative noncoding RNAs under clinical and preclinical trials for hepatocellular carcinoma therapeutics
TargetNameContentVendorCurrent status
MiR34MRX34Liposome-formulated miR-34 mimicMirna TherapeuticsPhase I
VEGF/KSPALN-VSPRNAi targeting VEGF/KSPAlnylam PharmaceuticalsPhase I
PLK1TMK-PLK1RNAi targeting PLK1Tekmira PharmaceuticalsPhase I/II
MiR21Anti-miR21Antisense against miR21Regulus TherapeuticsPreclinical
MiR221Anti-miR221Antisense against miR221Regulus TherapeuticsPreclinical
MiR7MiR7 mimicMiR7 mimicMiRevenPreclinical